Clinical Trial Update: A Study to Investigate the Safety, Tolerability, PK, PD, and Efficacy of ONO-7018 in Patients With R/R NHL or CLL [Phase 1]

View source ↗

Summary

Phase 1 study update for ONO-7018 in relapsed/refractory non-Hodgkin lymphoma and chronic lymphocytic leukemia, assessing safety, tolerability, PK, PD, and prel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Non-hodgkin Lymphoma

Drugs mentioned

• ONO-7018

Snippet

Sponsor: Ono Pharmaceutical Co., Ltd. | Conditions: Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell | Phase 1 | Status: ACTIVE_NOT_RECRUITING